Clinical trial
Dose Response of Inhaled Tacrolimus in Patients With Moderate Persistent Asthma
NCT00189787 · Astellas Pharma Inc, Industry · Completed
Key facts
| NCT number | NCT00189787 |
|---|---|
| Title | Dose Response of Inhaled Tacrolimus in Patients With Moderate Persistent Asthma |
| Lead sponsor | Astellas Pharma Inc, Industry |
| Collaborators | Astellas Pharma Europe B.V. Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Asthma, Bronchial, Bronchial Asthma |
| Intervention type | Drug |
| Interventions | tacrolimus |
| Enrollment | 370 |
| Primary completion | Aug 1, 2005 |
| Completion | Aug 1, 2005 |
| First posted | Sep 19, 2005 |
| Last update posted | Apr 17, 2008 |
| Countries | Bulgaria, Czechia, Germany, Hungary, Poland, Russia, Ukraine |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: